ANLI(SZ:300218) Xin Lang Zheng Quan·2025-11-17 06:05Core Viewpoint - Amway Co., Ltd. has experienced a decline in stock price and financial performance, with a notable decrease in revenue and net profit for the first nine months of 2025, indicating potential challenges ahead for the company [1][2]. Financial Performance - As of November 10, 2025, Amway Co., Ltd. reported a revenue of 1.679 billion yuan, a year-on-year decrease of 6.84% [2]. - The net profit attributable to shareholders for the same period was 121 million yuan, reflecting a decline of 19.22% year-on-year [2]. - The company's stock price has increased by 20.03% year-to-date, but has seen a decline of 17.62% over the past 60 days [1]. Shareholder Information - As of November 10, 2025, the number of shareholders increased by 8.63% to 18,400, while the average circulating shares per person decreased by 7.95% to 11,729 shares [2]. - The company has distributed a total of 341 million yuan in dividends since its A-share listing, with 131 million yuan distributed over the past three years [3]. Major Shareholders - As of September 30, 2025, the top ten circulating shareholders included several new entrants, such as Yongying Advanced Manufacturing Mixed Fund and Jiang Hai Securities Co., Ltd., indicating a shift in institutional holdings [3]. - Notably, Guotai Junan Innovation Growth Mixed Fund reduced its holdings by 5.05 million shares, while other funds entered the top ten list [3]. Company Overview - Amway Co., Ltd. specializes in the research, production, and sales of ecological functional polyurethane synthetic leather and composite materials, with 94.05% of its revenue coming from ecological functional synthetic leather [1]. - The company is classified under the basic chemicals industry, specifically in the plastics sector, and is involved in various concept sectors including graphene and automotive parts [1].